1. |
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58(4): 512-521.
|
2. |
Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58(4): 522-530.
|
3. |
GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet, 2018, 391(10136): 2236-2271.
|
4. |
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 2018, 91(2): 82-90.
|
5. |
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 2018, 91(2): 74-81.
|
6. |
中国抗癫痫协会. 临床诊疗指南: 癫痫病分册. 北京: 人民卫生出版社, 2015.
|
7. |
中国抗癫痫协会共患病专业委员会. 癫痫伴焦虑诊断治疗的中国专家共识. 癫痫杂志, 2018, 4(3): 185-191.
|
8. |
中国抗癫痫协会共患病专业委员会. 儿童癫痫共患注意缺陷多动障碍诊断治疗的中国专家共识. 癫痫杂志, 2018, 4(4): 281-289.
|
9. |
中国抗癫痫协会共患病专业委员会. 儿童癫痫共患孤独症谱系障碍诊断治疗的中国专家共识. 癫痫杂志, 2019, 5(1): 3-10.
|
10. |
Yu P, Zhou D, Liao W, et al. An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China. Epilepsy Behav, 2017, 69: 126-132.
|
11. |
Hao X, Chen Z, Yan B, et al. Impact of drug manipulation on seizure freedom in adults with uncontrolled epilepsy: a prospective controlled study in rural China. CNS Drugs, 2017, 31(3): 237-243.
|
12. |
Chi X, Li R, Hao X, et al. Response to treatment schedules after the first antiepileptic drug failed. Epilepsia, 2018, 59(11): 2118-2124.
|
13. |
Wu XT, Hu FY, An DM, et al. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China. Epilepsy Behav, 2010, 19(3): 405-408.
|
14. |
Cheung YK, Cheng SH, Chan EJ, et al. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia, 2013, 54(7): 1307-1314.
|
15. |
Shi YW, Min FL, Zhou D, et al. HLA-A*24: 02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions. Neurology, 2017, 88(23): 2183-2191.
|
16. |
Guo J, Guo J, Li J, et al. Statin treatment reduces the risk of poststroke seizures. Neurology, 2015, 85(8): 701-707.
|
17. |
Trinka E, Kwan P, Lee B, et al. Epilepsy in Asia: Disease burden, management barriers, and challenges. Epilepsia, 2019, 60(Suppl 1): 7-21.
|
18. |
Wei PH, An Y, Fan XT, et al. Stereoelectroencephalography-guided radiofrequency thermocoagulation for hypothalamic hamartomas: preliminary evidence. World Neurosurg, 2018, 114: e1073-1078.
|
19. |
Yu T, Wang X, Li Y, et al. High-frequency stimulation of anterior nucleus of thalamus desynchronizes epileptic network in humans. Brain, 2018, 141(9): 2631-2643.
|
20. |
Mu J, Liu L, Zhang Q, et al. Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology, 2011, 77(2): 132-137.
|
21. |
Ge Y, Ding D, Zhang Q, et al. Incidence of sudden unexpected death in epilepsy in community-based cohort in China. Epilepsy Behav, 2017, 76: 76-83.
|
22. |
Si Y, Chen D, Tian L, et al. Update on causes of premature death in people with convulsive epilepsy in rural West China. Epilepsia, 2016, 57(6): e117-120.
|
23. |
Tong X, An D, Lan L, et al. Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China. Epilepsy Behav, 2015, 47: 6-10.
|
24. |
Tong X, An D, Mcgonigal A, et al. Validation of the Generalized Anxiety Disorder-7(GAD-7) among Chinese people with epilepsy. Epilepsy Res, 2016, 120: 31-36.
|
25. |
Chen S, Wu X, Lui S, et al. Resting-state fMRI study of treatment-naive temporal lobe epilepsy patients with depressive symptoms. Neuro Image, 2012, 60(1): 299-304.
|
26. |
Xiao F, An D, Lei D, et al. Real-time effects of centrotemporal spikes on cognition in rolandic epilepsy: An EEG-fMRI study. Neurology, 2016, 86(6): 544-551.
|
27. |
Wu XQ, Zhao YN, Ding J, et al. Decreased vesicular acetylcholine transporter related to memory deficits in epilepsy: A[(18) F] VAT positron emission tomography brain imaging study. Epilepsia, 2018, 59(9): 1655-1666.
|
28. |
Jiang Y, Han CL, Liu HG, et al. Abnormal hippocampal functional network and related memory impairment in pilocarpine-treated rats. Epilepsia, 2018, 59(9): 1785-1795.
|
29. |
Hu J, Si Y, Zhou D, et al. Prevalence and treatment gap of active convulsive epilepsy: a large community-based survey in rural West China. Seizure, 2014, 23(5): 333-337.
|
30. |
Zhao Y, Zhang Q, Tsering T, et al. Prevalence of convulsive epilepsy and health-related quality of life of the population with convulsive epilepsy in rural areas of Tibet Autonomous Region in China: an initial survey. Epilepsy Behav, 2008, 12(3): 373-381.
|
31. |
Wang WZ, Wu JZ, Wang DS, et al. The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology, 2003, 60(9): 1544-1545.
|
32. |
Yu J, Luo N, Wang Z, et al. Current status of epilepsy treatment and efficacy of standard Phenobarbital therapy in rural areas of Northern China. Int J Neurosci, 2017, 127(8): 659-666.
|
33. |
Li J, Si Y, Hu J, et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia, 2013, 54(11): 1988-1996.
|
34. |
国家神经内科医疗质量控制中心. 2017 神经内科医疗质量报告. 北京: 人民卫生出版社, 2018: 68-101.
|